Rob Mulfinger

Rob Mulfinger is a results-oriented healthcare executive with over 25 years of progressive leadership experience across multi-site healthcare, healthcare IT and medtech at both Fortune 500 and PE-backed companies. Rob has a proven track record in P&L, operations, customer service, marketing, strategic planning, sales, and large workforce management. Most recently, Rob was the Chief Commercial Officer at PE-backed Cranial Technologies, a developer and manufacturer of an FDA-cleared cranial re-modeling device for the treatment of plagiocephaly in infants delivered through a national footprint of more than 90 owned and operated centers. While at Cranial Technologies, Rob oversaw all clinic operations, sales and marketing while growing the Company via a proven and successful multi-site de novo strategy. The company experienced multiple successful exits under Rob’s leadership. Prior to Cranial Technologies, Rob was the co-founder of an HCIT provider services business, and before that spent nearly a decade at Siemens Medical Solutions.

Mr. Mulfinger earned a bachelor’s degree from Vanderbilt University and an MBA from the University of Notre Dame.